Table:
begin	end	state
1	64	cytoplasmic
65	85	transmembrane
86	90	non-cytoplasmic
91	107	transmembrane
108	143	cytoplasmic
144	166	transmembrane
167	170	non-cytoplasmic
171	189	transmembrane
190	197	cytoplasmic
198	220	transmembrane
221	241	non-cytoplasmic
242	264	transmembrane
265	284	cytoplasmic
285	306	transmembrane
307	318	non-cytoplasmic
319	344	transmembrane
345	375	cytoplasmic
376	398	transmembrane
399	403	non-cytoplasmic
404	423	transmembrane
424	443	cytoplasmic
444	465	transmembrane
466	470	non-cytoplasmic
471	490	transmembrane
491	506	cytoplasmic

Input:
>H281DRAFT_04042
VPVRCKKSAGWYQYLGNIGRGKIFGSAGADHKSGRAIEIHTLGRNLDNALQQDGLKRGLK
NRHIQLIALGGAIGTGLFLGSASVLQAAGPSMILGYAIGGVIAFMIMRQLGEMVAQEPVA
GSFSHFAYKYWGDFPGFLSGWNYWVLYVLVSMAELTAVGTYVHYWWPGVPTWVSALVCFA
GINAINLANVKAYGETEFWFAIIKVVAVIGMILFGGYLLVSGHGGPQASISNLWSHGGFF
PHGFHGLFTMLAVIMFSFGGLELIGITAAEADEPQKSIPKAVNQVIYRILIFYICSLAVL
LSLYPWNEVAAGGSPFVMIFSQIGSTLTANVLNVVVLTAALSVYNSGVYANSRMLYGLAE
QGNAPRALMKVDRRGVPYMAIGLSALATFTCVIVNYLIPAEALGLLMALVVAALVLNWAL
ISLTHLKSRRAMVAAGETLVFKSFWFPVSNWICLAFMALILVILAMTPGLSVSVLLVPVW
LVVMWAGYAFKRRRAAAHVAARVVGR

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server